Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056–66.

Article  PubMed  Google Scholar 

Pandey P, Steinberg GK. Neurosurgical advances in the treatment of moyamoya disease. Stroke. 2011;42(11):3304–10.

Article  PubMed  Google Scholar 

Pollak L. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;361(1):98. author reply.

PubMed  Google Scholar 

Bang OY, Toyoda K, Arenillas JF, Liu L, Kim JS. Intracranial large artery disease of non-atherosclerotic origin: recent progress and clinical implications. J Stroke. 2018;20(2):208–17.

Article  PubMed  PubMed Central  Google Scholar 

Kim JS. Moyamoya Disease: Epidemiology, clinical features, and diagnosis. J Stroke. 2016;18(1):2–11.

Article  MathSciNet  PubMed  PubMed Central  Google Scholar 

Wang X, Wang Y, Nie F, Li Q, Zhang K, Liu M, et al. Association of Genetic Variants with Moyamoya Disease in 13 000 individuals: a Meta-analysis. Stroke. 2020;51(6):1647–55.

Article  PubMed  Google Scholar 

Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997;99(Suppl 2):1–5.

Article  Google Scholar 

Bao XY, Wang QN, Zhang Y, Zhang Q, Li DS, Yang WZ, et al. Epidemiology of Moyamoya Disease in China: Single-Center, Population-based study. World Neurosurg. 2019;122:e917–e23.

Article  PubMed  Google Scholar 

Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, et al. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022;21(8):747–58.

Article  PubMed  Google Scholar 

Bao XY, Duan L, Li DS, Yang WZ, Sun WJ, Zhang ZS, et al. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China. Cerebrovasc Dis. 2012;34(4):305–13.

Article  PubMed  Google Scholar 

Zhao Y, Lu J, Yu S, Li J, Deng X, Zhang Y, et al. Comparison of Long-Term Effect between Direct and Indirect Bypass for Pediatric ischemic-type Moyamoya Disease: a propensity score-matched study. Front Neurol. 2019;10:795.

Article  PubMed  PubMed Central  Google Scholar 

Noh HJ, Kim SJ, Kim JS, Hong SC, Kim KH, Jun P, et al. Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease. J Neurol Sci. 2015;359(1–2):381–8.

Article  PubMed  Google Scholar 

Ge P, Ye X, Liu X, Deng X, Wang R, Zhang Y, et al. Association between p.R4810K variant and long-term clinical outcome in patients with Moyamoya Disease. Front Neurol. 2019;10:662.

Article  PubMed  PubMed Central  Google Scholar 

Yu X, Ge P, Zhai Y, Wang R, Zhang Y, Zhang D. Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease. Front Neurol. 2022;13:891622.

Article  PubMed  PubMed Central  Google Scholar 

Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore MD). 2016;64(1):73–84.

Article  PubMed  Google Scholar 

Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007;13(10):1579–84.

Article  PubMed  PubMed Central  Google Scholar 

Hu J, Xu Y, He Z, Zhang H, Lian X, Zhu T, et al. Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis. Oncotarget. 2018;9(2):2752–60.

Article  PubMed  Google Scholar 

Xu J, Dai L, Zhang Y, Wang A, Li H, Wang Y, et al. Severity of nonalcoholic fatty liver disease and risk of future ischemic stroke events. Stroke. 2021;52(1):103–10.

Article  PubMed  Google Scholar 

Wannamethee SG, Lennon L, Shaper AG. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis. 2008;201(1):168–75.

Article  PubMed  Google Scholar 

Sato F, Nakamura Y, Kayaba K, Ishikawa S. TG/HDL-C ratio as a predictor of stroke in the population with healthy BMI: the Jichi Medical School Cohort Study. Nutrition, metabolism, and cardiovascular diseases. NMCD. 2022;32(8):1872–9.

PubMed  Google Scholar 

Guidelines for diagnosis. And treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurologia medico-chirurgica. 2012;52(5):245–66.

Article  Google Scholar 

Farrell GC, Chitturi S, Lau GK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol. 2007;22(6):775–7.

Article  PubMed  Google Scholar 

Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, Wang BY, et al. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis. 2008;9(2):108–12.

Article  PubMed  Google Scholar 

Targher G, Corey KE, Byrne CD. NAFLD, and cardiovascular and cardiac diseases: factors influencing risk, prediction and treatment. Diabetes Metab. 2021;47(2):101215.

Article  PubMed  Google Scholar 

Galiero R, Caturano A, Vetrano E, Cesaro A, Rinaldi L, Salvatore T, et al. Pathophysiological mechanisms and clinical evidence of relationship between nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease. Rev Cardiovasc Med. 2021;22(3):755–68.

Article  PubMed  Google Scholar 

Guo K, Zhang L, Lu J, Yu H, Wu M, Bao Y, et al. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes. J Diabetes Complicat. 2017;31(1):80–5.

Article  Google Scholar 

Koenig G, Seneff S, Gamma-Glutamyltransferase. A predictive biomarker of Cellular antioxidant inadequacy and Disease Risk. Dis Markers. 2015;2015:818570.

Article  PubMed  PubMed Central  Google Scholar 

Franzini M, Corti A, Martinelli B, Del Corso A, Emdin M, Parenti GF, et al. Gamma-glutamyltransferase activity in human atherosclerotic plaques–biochemical similarities with the circulating enzyme. Atherosclerosis. 2009;202(1):119–27.

Article  PubMed  Google Scholar 

Kasumov T, Edmison JM, Dasarathy S, Bennett C, Lopez R, Kalhan SC. Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease. Metab Clin Exp. 2011;60(6):776–81.

Article  PubMed  Google Scholar 

Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115(10):1285–95.

Article  PubMed  Google Scholar 

Bruyndonckx L, Hoymans VY, Van Craenenbroeck AH, Vissers DK, Vrints CJ, Ramet J, et al. Assessment of endothelial dysfunction in childhood obesity and clinical use. Oxidative Med Cell Longev. 2013;2013:174782.

Article  Google Scholar 

Chiang CH, Huang PH, Chung FP, Chen ZY, Leu HB, Huang CC, et al. Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease. PLoS ONE. 2012;7(2):e31799.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Coulon S, Francque S, Colle I, Verrijken A, Blomme B, Heindryckx F, et al. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. Cytokine. 2012;59(2):442–9.

Article  PubMed  Google Scholar 

Coulon S, Legry V, Heindryckx F, Van Steenkiste C, Casteleyn C, Olievier K, et al. Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models. Hepatology (Baltimore MD). 2013;57(5):1793–805.

Article  PubMed  Google Scholar 

Escudero C, Acurio J, López E, Rodríguez A, Benavente A, Lara E, et al. Vascular endothelial growth factor and poor prognosis after ischaemic stroke. Eur J Neurol. 2021;28(5):1759–64.

Article  PubMed  Google Scholar 

Holmes MV, Millwood IY, Kartsonaki C, Hill MR, Bennett DA, Boxall R, et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol. 2018;71(6):620–32.

Article  PubMed  PubMed Central  Google Scholar 

Lu S, Xie Q, Kuang M, Hu C, Li X, Yang H, et al. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. J Translational Med. 2023;21(1):192.

Article  Google Scholar 

Trauner M, Arrese M, Wagner M. Fatty liver and lipotoxicity. Biochim Biophys Acta. 2010;1801(3):299–310.

Article  PubMed  Google Scholar 

Sarkar P, Thirumurugan K. New insights into TNFα/PTP1B and PPARγ pathway through RNF213- a link between inflammation, obesity, insulin resistance, and Moyamoya disease. Gene. 2021;771:145340.

Article  PubMed  Google Scholar 

Piccolis M, Bond LM, Kampmann M, Pulimeno P, Chitraju C, Jayson CBK, et al. Probing the Global Cellular responses to Lipotoxicity caused by saturated fatty acids. Mol Cell. 2019;74(1):32–44e8.

Article  PubMed  PubMed Central  Google Scholar 

Raza S, Rajak S, Upadhyay A, Tewari A, Anthony Sinha R. Current treatm